In pancreatic cancer cells harboring oncogenic Ras mutations, the Erk-MAPK pathway phosphorylates KLF11, thereby impairing its association with mSin3A corepressor and inhibiting Smad7 suppression. Here, KLF11 is linked to pancreatic neoplasm.